litlas
Log inCreate account

C. Patrick Reynolds

Active 1978–2025

115
Papers
23,212
Citations
85
h-index
110
i10-index

Citations

Citations per year for C. Patrick Reynolds1976: 1 citations1979: 3 citations1980: 1 citations1981: 3 citations1982: 4 citations1984: 1 citations1985: 8 citations1986: 15 citations1987: 7 citations1988: 8 citations1989: 12 citations1990: 16 citations1991: 16 citations1992: 31 citations1993: 50 citations1994: 59 citations1995: 70 citations1996: 54 citations1997: 64 citations1998: 54 citations1999: 65 citations2000: 91 citations2001: 103 citations2002: 86 citations2003: 110 citations2004: 86 citations2005: 74 citations2006: 100 citations2007: 117 citations2008: 125 citations2009: 148 citations2010: 240 citations2011: 212 citations2012: 236 citations2013: 202 citations2014: 223 citations2015: 230 citations2016: 170 citations2017: 182 citations2018: 195 citations2019: 624 citations2020: 659 citations2021: 593 citations2022: 455 citations2023: 274 citations2024: 458 citations2025: 173 citations2026: 6 citations1977–1978: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,515 citing papers, 34.1% of this breakdownChina: 620 citing papers, 8.4% of this breakdownGermany: 421 citing papers, 5.7% of this breakdownUnited Kingdom: 386 citing papers, 5.2% of this breakdownItaly: 345 citing papers, 4.7% of this breakdownFrance: 292 citing papers, 4% of this breakdownCanada: 238 citing papers, 3.2% of this breakdownAustralia: 231 citing papers, 3.1% of this breakdownJapan: 214 citing papers, 2.9% of this breakdownNetherlands: 192 citing papers, 2.6% of this breakdownSpain: 172 citing papers, 2.3% of this breakdownSwitzerland: 157 citing papers, 2.1% of this breakdown
0%34.1%Other 21.7%

Institutions

Fields

  • Medicine51.4%
  • Biochemistry, Genetics and Molecular Biology34.6%
  • Immunology and Microbiology5.6%
  • Neuroscience2.1%
  • Materials Science1.4%
  • Engineering1.3%
  • Other3.6%

Topics

  • Neuroblastoma Research and Treatments9.5%
  • Cancer, Hypoxia, and Metabolism4.5%
  • CAR-T cell therapy research2.3%
  • Cancer therapeutics and mechanisms2.3%
  • Cell death mechanisms and regulation2.1%
  • Sarcoma Diagnosis and Treatment1.5%
  • Other77.8%

Coauthors

All papers

Open in search
  1. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Authors: Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak, Wendy B. London, Susan G. Kreissman, Helen X. Chen, Malcolm A. Smith, Barry Anderson, Judith G. Villablanca, Katherine K. Matthay, Hiro Shimada, Stephan A. Grupp, Robert C. Seeger, C. Patrick Reynolds, Allen Buxton, Ralph A. Reisfeld, S. D. Gillies, Susan L. Cohn, John M. Maris, Paul M. Sondel - New England Journal of Medicine 2010 cited by 1,809

  2. Determination of subcutaneous tumor size in athymic (nude) mice

    Authors: Mary M. Tomayko, C. Patrick Reynolds - Cancer Chemotherapy and Pharmacology 1989 cited by 1,830

  3. Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

    Authors: Min H. Kang, C. Patrick Reynolds - Clinical Cancer Research 2009 cited by 1,021

  4. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Authors: Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger, Hiroyuki Shimada, E. Stanton Adkins, Daphne A. Haas‐Kogan, Robert B. Gerbing, Wendy B. London, Judith G. Villablanca - Journal of Clinical Oncology 2009 cited by 856

  5. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

    Authors: Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger, Daniel O. Stram, Richard E. Harris, Norma K.C. Ramsay, Patrick S. Swift, Hiroyuki Shimada, Charles T. Black, Garrett M. Brodeur, Robert B. Gerbing, C. Patrick Reynolds - New England Journal of Medicine 1999 cited by 1,903

  6. Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines

    Authors: Jo Lynne Harenza, Maura Diamond, Rebecca N. Adams, Michael M. Song, Heather L. Davidson, Lori S. Hart, Maiah H. Dent, Paolo Fortina, C. Patrick Reynolds, John M. Maris - Scientific Data 2017 cited by 178

  7. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

    Authors: Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas, Kristen Upton, Joy C. Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika S. Gaonkar, Apexa Modi, Esther R. Berko, Gonzalo López, Zalman Vaksman, Chelsea Mayoh, Jonas Nance, Kristyn McCoy, Michelle Haber, Kathryn Evans, Hannah McCalmont, Katerina Bendak, Julia Böhm, Glenn M. Marshall, Vanessa Tyrrell, Karthik Kalletla, Frank Braun, Lin Qi, Yunchen Du, Huiyuan Zhang, Holly Lindsay, Sibo Zhao, Jack Shu, Patricia Baxter, Christopher L. Morton, Dias Kurmashev, Siyuan Zheng, Yidong Chen, Jay Bowen, Anthony C. Bryan, Kristen Leraas, Sara E. Coppens, HarshaVardhan Doddapaneni, Zeineen Momin, Wendong Zhang, Gregory I. Sacks, Lori S. Hart, Kateryna Krytska, Yaël P. Mossé, Gregory J. Gatto, Yolanda Sánchez, Casey S. Greene, Sharon J. Diskin, Olena M. Vaske, David Haussler, Julie M. Gastier‐Foster, E. Anders Kolb, Richard Görlick, Xiao-Nan Li, C. Patrick Reynolds, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock, Pichai Raman, David A. Wheeler, John M. Maris - Cell Reports 2019 cited by 173

  8. Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    Authors: Wendy B. London, R P Castleberry, Katherine K. Matthay, A. Thomas Look, Robert C. Seeger, Hiroyuki Shimada, Paul S. Thorner, G M Brodeur, John M. Maris, C. Patrick Reynolds, Susan L. Cohn - Journal of Clinical Oncology 2005 cited by 587

  9. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

    Authors: Mark Sausen, Rebecca Leary, Siân Jones, Jian Wu, C. Patrick Reynolds, Xueyuan Liu, Amanda L. Blackford, Giovanni Parmigiani, Luis A. Díaz, Nickolas Papadopoulos, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Michael D. Hogarty - Nature Genetics 2012 cited by 415

  10. A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

    Authors: Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho, Min H. Kang, Susan L. Cohn, Clarke P. Anderson, Araz Marachelian, Susan Groshen, Denice Tsao‐Wei, Katherine K. Matthay, John M. Maris, Charlotte E. Hasenauer, Scarlett Czarnecki, Hollie Lai, Fariba Goodarzian, Hiro Shimada, C. Patrick Reynolds - Pediatric Blood & Cancer 2016 cited by 95

  11. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer

    Authors: Veena Coothankandaswamy, Sha Cao, Ying Xu, Puttur D. Prasad, Pankaj K. Singh, C. Patrick Reynolds, Shengping Yang, Jiro Ogura, Vadivel Ganapathy, Yangzom D. Bhutia - British Journal of Pharmacology 2016 cited by 136

  12. miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma

    Authors: Srinivas Chava, C. Patrick Reynolds, Anup S. Pathania, Santhi Gorantla, Larisa Y. Poluektova, Donald W. Coulter, Subash C. Gupta, Manoj K. Pandey, Kishore B. Challagundla - Molecular Oncology 2019 cited by 158

  13. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma

    Authors: Carol J. Thiele, C. Patrick Reynolds, Mark A. Israel - Nature 1985 cited by 649

  14. Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641

    Authors: Douglas Strother, Wendy B. London, Mary Lou Schmidt, Garrett M. Brodeur, Hiroyuki Shimada, Paul S. Thorner, Margaret H. Collins, Edward P. Tagge, Stanton Adkins, C. Patrick Reynolds, Kevin Murray, Robert S. Lavey, Katherine K. Matthay, Robert P. Castleberry, John M. Maris, Susan L. Cohn - Journal of Clinical Oncology 2012 cited by 239

  15. The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma

    Authors: Ashujit Tagde, Harpal Singh, Min H. Kang, C. Patrick Reynolds - Blood Cancer Journal 2014 cited by 124

  16. Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression

    Authors: Min H. Kang, Jing Wang, Monish Ram Makena, Joo-Sang Lee, Nancy Paz, Connor P. Hall, Michael M. Song, Ruben I. Calderon, Riza E. Cruz, Ashly Hindle, Winford Ko, Jonathan B. Fitzgerald, Daryl C. Drummond, Timothy J. Triche, C. Patrick Reynolds - Clinical Cancer Research 2015 cited by 100

  17. ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156

    Authors: Balakrishna Koneru, Ahsan Farooqi, Thinh H. Nguyen, Wan Hsi Chen, Ashly Hindle, Cody Eslinger, Monish Ram Makena, Trevor A. Burrow, Joanne Wilson, Aaron Smith, Venkatesh Pilla Reddy, Elaine Cadogan, Stephen T. Durant, C. Patrick Reynolds - Science Translational Medicine 2021 cited by 58

  18. Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance

    Authors: Jorida Çoku, David M. Booth, J. Škoda, Madison C Pedrotty, Jennifer Vogel, Kangning Liu, Annette Vu, Erica L. Carpenter, Jamie C. Ye, Michelle A. Chen, Peter J. Dunbar, Elizabeth O. Scadden, Taekyung D. Yun, Eiko Nakamaru‐Ogiso, Estela Área-Gómez, Yimei Li, Kelly C. Goldsmith, C. Patrick Reynolds, György Hajnóczky, Michael D. Hogarty - The EMBO Journal 2022 cited by 31

  19. The pediatric preclinical testing program: Description of models and early testing results

    Authors: Peter J. Houghton, Christopher L. Morton, Chandra L. Tucker, Debbie Payne, Edward Favours, Claire Cole, Richard Görlick, E. Anders Kolb, Wendong Zhang, Richard B. Lock, Hernán Carol, Mimi Tajbakhsh, C. Patrick Reynolds, John M. Maris, Joshua Courtright, Stephen T. Keir, Henry S. Friedman, Charles M. Stopford, Joseph Zeidner, Jianrong Wu, Tiebin Liu, Catherine A. Billups, Javed Khan, Sherry S. Ansher, Jian Zhang, Malcolm A. Smith - Pediatric Blood & Cancer 2006 cited by 483

  20. The two different receptors for tumor necrosis factor mediate distinct cellular responses.

    Authors: Louis A. Tartaglia, R F Weber, Irene S. Figari, C. Patrick Reynolds, Michael A. Palladino, David V. Goeddel - National Academy of Sciences, Proceedings of the National Academy of Sciences 1991 cited by 814

  21. Retinoid therapy of high-risk neuroblastoma

    Authors: C. Patrick Reynolds, Katherine K. Matthay, Judith G. Villablanca, Barry J. Maurer - Cancer Letters 2003 cited by 335

  22. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma

    Authors: Balakrishna Koneru, Gonzalo López, Ahsan Farooqi, Karina L. Conkrite, Thinh H. Nguyen, Shawn J. Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle, Heather L. Davidson, Kristyn McCoy, Jonas Nance, Vanda Yazdani, Meredith S. Irwin, Shengping Yang, David A. Wheeler, John M. Maris, Sharon J. Diskin, C. Patrick Reynolds - Cancer Research 2020 cited by 112

  23. Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

    Authors: Kateryna Krytska, Hannah T. Ryles, Renata Sano, Pichai Raman, Nicole R. Infarinato, Theodore D. Hansel, Monish Ram Makena, Michael M. Song, C. Patrick Reynolds, Yaël P. Mossé - Clinical Cancer Research 2015 cited by 105

  24. Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

    Authors: Caitlin D. Lowery, Michele Dowless, Matthew Renschler, Wayne Blosser, Alle B. VanWye, Jennifer R. Stephens, Philip W. Iversen, Aimee Bence Lin, Richard P. Beckmann, Kateryna Krytska, Kristina A. Cole, John M. Maris, Douglas S. Hawkins, Brian P. Rubin, Raushan T. Kurmasheva, Peter J. Houghton, Richard Görlick, E. Anders Kolb, Min H. Kang, C. Patrick Reynolds, Stephen W. Erickson, Beverly A. Teicher, Malcolm A. Smith, Louis F. Stancato - Clinical Cancer Research 2018 cited by 80